Bonesupport Holding AB
STO:BONEX
Bonesupport Holding AB
STO:BONEX
Price:
240 SEK
-1.72%
Updated:
May 17, 2024
Section:
Relative Value
The Relative Value of one
BONEX
stock under the Base Case scenario is
189.74
SEK.
Compared to the current market price of 240 SEK,
Bonesupport Holding AB
is
Overvalued by 21%.
Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.
Relative Valuation FAQ:
BONEX
Relative Value
Base Case
189.74
SEK
Overvaluation 21%
Valuation Multiples
Multiples Across Competitors
BONEX Competitors Multiples
Bonesupport Holding AB Competitors
Bonesupport Holding AB Competitors
All Countries
| Market Cap | P/S | P/E | EV/EBITDA | EV/EBIT | ||||
|---|---|---|---|---|---|---|---|---|
| SE |
|
Bonesupport Holding AB
STO:BONEX
|
16B SEK | 24.4 | 60 | 282.7 | 348.2 | |
| US |
|
Abbvie Inc
NYSE:ABBV
|
291.9B USD | 5.4 | 60.5 | 13.1 | 20 | |
| US |
|
Amgen Inc
NASDAQ:AMGN
|
166.8B USD | 5.7 | 44.4 | 18.7 | 30.8 | |
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
113.9B USD | 11.5 | 31.5 | 25.5 | 26.7 | |
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
107.2B USD | 8.2 | 27.8 | 22.5 | 24.9 | |
| AU |
|
CSL Ltd
ASX:CSL
|
135.3B AUD | 6.4 | 36.6 | 22.1 | 27.4 | |
| US |
|
Gilead Sciences Inc
NASDAQ:GILD
|
84B USD | 3.1 | 173.6 | 7 | 9.1 | |
| US |
|
Moderna Inc
NASDAQ:MRNA
|
50.3B USD | 9.8 | -8.4 | -9.3 | -8.2 | |
| US |
|
Seagen Inc
NASDAQ:SGEN
|
43.1B USD | 18.8 | -57.5 | -61.9 | -55.8 | |
| US |
|
Biogen Inc
NASDAQ:BIIB
|
33.1B USD | 3.4 | 28.3 | 14.4 | 18 | |
| KR |
|
Celltrion Inc
KRX:068270
|
39.7T KRW | 18.2 | 74.1 | 45.3 | 62.4 |
P/S Multiple
P/E Multiple
EV/EBITDA Multiple
EV/EBIT Multiple
You don't have any saved screeners yet
